Sort
48,018 grants matching “immunotherapy”
Translational Research Central Services
$577,256Victor M Lemas · Johns Hopkins University · P30 · FY2024 · CA
Mast cell regulation of Th2 induction and tolerance breakdown in food allergy
$577,162Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2017 · AI
Mast cell regulation of Th2 induction and tolerance breakdown in food allergy
$577,162Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2019 · AI
Mast cell regulation of Th2 induction and tolerance breakdown in food allergy
$577,162Hans C. Oettgen · Boston Children'S Hospital · R01 · FY2016 · AI
Biologic Activity of Transferred HIV-specific CD8 Clones
$577,151Fred Hutchinson Cancer Research Center · U01 · FY2004 · AI
Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
$577,137Christiane Querfeld · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$577,130Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$577,095Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2020 · CA
Reprogramming PDAC tumor microenvironment to improve immunotherapy
$577,095Rakesh K. Jain · Massachusetts General Hospital · U01 · FY2021 · CA
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
$577,069David P Carbone · Ohio State University · R01 · FY2021 · CA
A Mechanoimmunological Basis for Metastatic Site Preference
$577,034Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
$577,033Alexander V Ljubimov · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an
$577,005Brian Quinn · Aktiv-Dry, Llc · R44 · FY2009 · DA
Molecular pathogenesis of Blastomycosis
$576,980Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2016 · AI
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
$576,966Yoon Yeo · Purdue University · R01 · FY2023 · CA
Research Program in Immunology
$576,958Ann Marshak-Rothstein · Boston University Medical Campus · T32 · FY2007 · AI
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2024 · CA
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2022 · CA
Biostatistics
$576,926Gary L Rosner · Johns Hopkins University · P30 · FY2023 · CA
Myeloid-lineage cells and immunopathology in Leishmania braziliensis
$576,914Phillip A. Scott · University Of Pennsylvania · U01 · FY2013 · AI
Project 2: Local immunotherapy corrects chemokine patterns in ovarian cancer
$576,791Robert Page Edwards · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
UW PET/CT Acquisition
$576,756Jamey P Weichert · University Of Wisconsin-Madison · S10 · FY2024 · OD
Systemic delivery of siRNA by Nanosac for checkpoint blockade immunotherapy of head and neck squamous cell cancer
$576,726Yoon Yeo · Purdue University · R01 · FY2022 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA